Publications
- Sequential decisions on FAS sequencing guided by biomarkers in patients with lymphoproliferation and autoimmune cytopenia2013 | Second Faculty of Medicine
- Minimal residual disease in peripheral blood at day 15 identifies a subgroup of childhood B-cell precursor acute lymphoblastic leukemia with superior prognosis2011 | Second Faculty of Medicine, First Faculty of Medicine, Faculty of Physical Education and Sport
- Detection of Residual B Precursor Lymphoblastic Leukemia by Uniform Gating Flow Cytometry2010 | Second Faculty of Medicine
- Minimal residual disease (MRD) analysis in the non-MRD-based ALL IC-BFM 2002 protocol for childhood ALL: is it possible to avoid MRD testing?2008 | Second Faculty of Medicine
- Phenotypic profiling of CD34+ cells by advanced flow cytometry improves diagnosis of Juvenile Myelomonocytic Leukemia2024 | Second Faculty of Medicine
- Minimal residual disease assessment in B-cell precursor acute lymphoblastic leukemia by semi-automated identification of normal hematopoietic cells: A EuroFlow study2024 | Second Faculty of Medicine
- CD371+ pediatric B-cell acute lymphoblastic leukemia: propensity to lineage switch and slow early response to treatment2024 | Second Faculty of Medicine
- The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms (vol 36, pg 1720, 2022)2023 | Second Faculty of Medicine, Faculty of Medicine in Pilsen
- Flow cytometric minimal residual disease assessment in B-cell precursor acute lymphoblastic leukaemia patients treated with CD19-targeted therapies - a EuroFlow study2022 | Second Faculty of Medicine
- Immunophenotypic Analysis of Acute Megakaryoblastic Leukemia: A EuroFlow Study2022 | Second Faculty of Medicine
Loading network view...